Aptevo Therapeutics Inc. (APVO)
NASDAQ · Healthcare
Aptevo Therapeutics Inc. Cash Flow 2015–2022
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Cash Flow | -25.6M | -23.8M | -11.7M | -21.0M | -21.7M | -29.3M | -42.4M | -51.4M | -41.6M |
| Depreciation & Amort. | 240,000 | 352,000 | 567,000 | 901,000 | 1.1M | 1.4M | 2.2M | 2.4M | 3.1M |
| Investing Activities | |||||||||
| Capital Expenditure | — | — | — | 29,000 | 713,000 | 88,000 | 153,000 | 976,000 | 1.4M |
| Free Cash Flow | — | — | — | -21.1M | -22.4M | -29.4M | -42.5M | -52.4M | -43.0M |
| Financing Activities | |||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — |
Aptevo Therapeutics Inc. Cash Flow — FAQ
Aptevo Therapeutics Inc. (APVO) cash flow over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see APVO's cash flow history?
The chart and table above show Aptevo Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.